| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.66 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.55 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.009 |